Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119109262 | 11910926 | 2 | F | 20120522 | 20160802 | 20160112 | 20160809 | EXP | JP-SA-2015SA092558 | AVENTIS | 74.00 | YR | E | F | Y | 49.00000 | KG | 20160809 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119109262 | 11910926 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | STRENGTH: 25MG | Y | UNKNOWN | 103869 | 122.5 | MG | INJECTION | |||||
| 119109262 | 11910926 | 2 | C | ASTRIC | ACYCLOVIR | 1 | Oral | DRY SYRUP | 0 | .5 | G | QD | |||||||
| 119109262 | 11910926 | 3 | C | BACTRAMIN | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 119109262 | 11910926 | 4 | C | MYCOSYST | FLUCONAZOLE | 1 | Oral | 0 | 200 | MG | QD | ||||||||
| 119109262 | 11910926 | 5 | C | NEORAL | CYCLOSPORINE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 119109262 | 11910926 | 6 | C | AMLODIN | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 119109262 | 11910926 | 7 | C | S. ADCHNON | 2 | Oral | 30 | 0 | 90 | MG | TABLET | QD | |||||||
| 119109262 | 11910926 | 8 | C | TRANSAMIN | TRANEXAMIC ACID | 1 | Oral | 0 | 750 | MG | CAPSULE | QD | |||||||
| 119109262 | 11910926 | 9 | C | LOXOPROFEN SODIUM | LOXOPROFEN SODIUM | 1 | Oral | 60 MG | 0 | TABLET | |||||||||
| 119109262 | 11910926 | 10 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | 50 ML | 0 | |||||||||||
| 119109262 | 11910926 | 11 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | 100 ML | 0 | |||||||||||
| 119109262 | 11910926 | 12 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Intravenous drip | 500 ML | 0 | ||||||||||
| 119109262 | 11910926 | 13 | C | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | 10000 UNITS/10 ML | 0 | |||||||||||
| 119109262 | 11910926 | 14 | C | ROCAIN | 2 | 0 | |||||||||||||
| 119109262 | 11910926 | 15 | C | METHYLPREDNISOLONE SODIUM SUCCINATE. | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 125 MG | 0 | INJECTION | ||||||||||
| 119109262 | 11910926 | 16 | C | FLOMOX | CEFCAPENE PIVOXIL HYDROCHLORIDE HYDRATE | 1 | 0 | ||||||||||||
| 119109262 | 11910926 | 17 | C | BIOFERMLN-R | 2 | 0 | TABLET | ||||||||||||
| 119109262 | 11910926 | 18 | C | PREDNISOLONE. | PREDNISOLONE | 1 | STRENGTH: 5MG | 0 | TABLET | ||||||||||
| 119109262 | 11910926 | 19 | C | MOHRUS | KETOPROFEN | 1 | STRENGTH: 30MG | 0 | |||||||||||
| 119109262 | 11910926 | 20 | C | SENNOSIDE | SENNOSIDES | 1 | STRENGTH: 12MG | 0 | TABLET | ||||||||||
| 119109262 | 11910926 | 21 | C | CRAVIT | LEVOFLOXACIN | 1 | 0 | TABLET | |||||||||||
| 119109262 | 11910926 | 22 | C | HYALEIN | HYALURONATE SODIUM | 1 | Ophthalmic | 0 | |||||||||||
| 119109262 | 11910926 | 23 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | 5MG | 0 | TABLET | ||||||||||
| 119109262 | 11910926 | 24 | C | EXJADE | DEFERASIROX | 1 | 0 | DISPERSIBLE TABLET | |||||||||||
| 119109262 | 11910926 | 25 | C | LACTATE RINGER SOLUTION/MALTOSE | 2 | 500ML | 0 | ||||||||||||
| 119109262 | 11910926 | 26 | C | POTACOL-R | 2 | 0 | INJECTION | ||||||||||||
| 119109262 | 11910926 | 27 | C | CARBOHYDRATES NOS/SODIUM LACTATE/SODIUM CHLORIDE/POTASSIUM CHLORIDE | 2 | 0 | |||||||||||||
| 119109262 | 11910926 | 28 | C | SOLYUGEN G | 2 | 500ML | 0 | ||||||||||||
| 119109262 | 11910926 | 29 | C | NISSEKI POLYGLOBIN-N | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119109262 | 11910926 | 1 | Aplastic anaemia |
| 119109262 | 11910926 | 2 | Prophylaxis |
| 119109262 | 11910926 | 3 | Prophylaxis |
| 119109262 | 11910926 | 4 | Prophylaxis |
| 119109262 | 11910926 | 5 | Aplastic anaemia |
| 119109262 | 11910926 | 6 | Hypertension |
| 119109262 | 11910926 | 7 | Prophylaxis |
| 119109262 | 11910926 | 8 | Prophylaxis |
| 119109262 | 11910926 | 15 | Prophylaxis |
| 119109262 | 11910926 | 16 | Prophylaxis |
| 119109262 | 11910926 | 17 | Prophylaxis |
| 119109262 | 11910926 | 21 | Prophylaxis |
| 119109262 | 11910926 | 29 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119109262 | 11910926 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119109262 | 11910926 | Febrile neutropenia | |
| 119109262 | 11910926 | Liver disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119109262 | 11910926 | 1 | 20120521 | 20120521 | 0 | |
| 119109262 | 11910926 | 2 | 20120521 | 20120828 | 0 | |
| 119109262 | 11910926 | 3 | 20120521 | 20120828 | 0 | |
| 119109262 | 11910926 | 4 | 20120521 | 20120828 | 0 | |
| 119109262 | 11910926 | 9 | 20120521 | 20120521 | 0 | |
| 119109262 | 11910926 | 10 | 20120502 | 20120831 | 0 | |
| 119109262 | 11910926 | 11 | 20120521 | 20121012 | 0 | |
| 119109262 | 11910926 | 12 | 20120521 | 20120522 | 0 | |
| 119109262 | 11910926 | 13 | 20120518 | 20121018 | 0 | |
| 119109262 | 11910926 | 14 | 20120518 | 20121018 | 0 | |
| 119109262 | 11910926 | 15 | 20120521 | 20120522 | 0 | |
| 119109262 | 11910926 | 16 | 20120510 | 0 |